A novel YAP inhibitor, CA3, has shown potent inhibitory effects on YAP/TEAD transcriptional activity and synergistic inhibition when combined with 5-FU especially in high YAP and resistant cells in Esophageal Adenocarcinoma [18]. Here, YAP1 is linked to esophageal adenocarcinoma.